Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CARA

Cara Therapeutics Inc

Dec 01 • 04:00PM ET

1.06

Dollar change +0.09
Percentage change 9.63	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.16	Insider Own	15.15%	Shs Outstand	53.80M	Perf Week	7.99%
Market Cap	57.75M	Forward P/E	-	EPS next Y	-1.82	Insider Trans	-0.20%	Shs Float	46.23M	Perf Month	-12.40%
Income	-116.52M	PEG	-	EPS next Q	-0.47	Inst Own	52.34%	Short Float / Ratio	7.40% / 5.51	Perf Quarter	-55.83%
Sales	21.23M	P/S	2.72	EPS this Y	-30.19%	Inst Trans	-0.37%	Short Interest	3.42M	Perf Half Y	-65.70%
Book/sh	1.57	P/B	0.67	EPS next Y	11.84%	ROA	-70.86%	Target Price	11.50	Perf Year	-91.02%
Cash/sh	1.45	P/C	0.73	EPS next 5Y	-	ROE	-86.16%	52W Range	0.90 - 12.81	Perf YTD	-90.13%
Dividend	-	P/FCF	-	EPS past 5Y	3.05%	ROI	-126.02%	52W High	-91.73%	Beta	0.81
Dividend %	-	Quick Ratio	4.25	Sales past 5Y	400.85%	Gross Margin	62.62%	52W Low	17.78%	ATR	0.11
Employees	106	Current Ratio	4.40	Sales Q/Q	-55.00%	Oper. Margin	-566.29%	RSI (14)	44.74	Volatility	10.43% 10.57%
Optionable	Yes	Debt/Eq	0.09	EPS Q/Q	-19.82%	Profit Margin	-548.95%	Rel Volume	0.95	Prev Close	0.97
Shortable	Yes	LT Debt/Eq	0.08	Earnings	Nov 13 AMC	Payout	-	Avg Volume	620.42K	Price	1.06
Recom	1.33	SMA20	-3.16%	SMA50	-19.30%	SMA200	-69.41%	Volume	590,600	Change	9.63%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-08-23	Downgrade	BofA Securities	Neutral → Underperform	$13 → $6
Mar-08-22	Upgrade	JP Morgan	Neutral → Overweight	$17 → $20
Nov-01-21	Resumed	Canaccord Genuity	Buy	$33
Aug-03-21	Initiated	JP Morgan	Neutral	$16
Apr-21-20	Reiterated	H.C. Wainwright	Buy	$30 → $33
Aug-12-19	Reiterated	H.C. Wainwright	Buy	$31 → $30
May-29-19	Reiterated	Laidlaw	Buy	$26 → $32
Feb-06-19	Resumed	Jefferies	Buy	$22
Jan-15-19	Initiated	BofA/Merrill	Neutral	$19
Sep-21-18	Initiated	Cantor Fitzgerald	Overweight
Sep-13-18	Initiated	Jefferies	Buy	$30
Aug-08-18	Reiterated	Stifel	Buy	$22 → $26
Jun-28-18	Reiterated	H.C. Wainwright	Buy	$24 → $26
Mar-12-18	Resumed	H.C. Wainwright	Buy	$22
Feb-12-18	Upgrade	Janney	Neutral → Buy
Jan-19-18	Initiated	Seaport Global Securities	Buy	$27
Jun-30-17	Reiterated	Stifel	Buy	$24 → $20
Jun-30-17	Reiterated	Laidlaw	Buy	$35 → $30
Jun-30-17	Downgrade	Janney	Buy → Neutral
Mar-28-17	Reiterated	Laidlaw	Buy	$20 → $35

Show Previous Ratings

Nov-14-23 11:04AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.20%
08:48AM	Q3 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-13-23 06:00PM	Cara (CARA) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +12.38%
04:15PM	Cara: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Cara Therapeutics Reports Third Quarter 2023 Financial Results (GlobeNewswire)
11:38AM	Loading…
Nov-09-23 11:38AM	These Biotech Stocks Could Double Your Money, According To Analysts (Benzinga) -6.72%
Nov-06-23 10:00AM	Earnings Preview: Cara Therapeutics (CARA) Q3 Earnings Expected to Decline (Zacks)
Nov-02-23 07:00AM	Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty (GlobeNewswire)
Oct-23-23 07:00AM	Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023 (GlobeNewswire)
Sep-25-23 07:00AM	Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients (GlobeNewswire)
Sep-05-23 07:00AM	Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire) -10.00%
Aug-10-23 02:53AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 05:54AM	Q2 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 05:15PM	Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.75%
04:09PM	Cara: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Loading…
04:01PM	Cara Therapeutics Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 07:00AM	Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors (GlobeNewswire)
Aug-02-23 07:00AM	Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-24-23 07:00AM	Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire)
Jun-14-23 01:37PM	The past five years for Cara Therapeutics (NASDAQ:CARA) investors has not been profitable (Simply Wall St.)
Jun-13-23 06:30AM	3 Small-Cap Stocks to Sell in June Before They Crash and Burn (InvestorPlace)
Jun-02-23 06:46PM	Palo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Jun-01-23 07:00AM	Cara Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-30-23 06:34PM	7 Stocks With 1,000% Upside Potential (InvestorPlace)
May-25-23 06:40AM	Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark (Simply Wall St.) -6.55%
May-18-23 04:53PM	Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich or Broke. (InvestorPlace) -8.22%
02:00AM	Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus (PR Newswire)
May-16-23 11:02AM	Q1 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +7.23%
May-15-23 05:15PM	Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Cara: Q1 Earnings Snapshot (AP Finance)
04:01PM	Loading…
04:01PM	Cara Therapeutics Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-04-23 09:38AM	Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 65% (Simply Wall St.)
May-01-23 07:00AM	Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 (GlobeNewswire)
Apr-26-23 08:00PM	CARA: What does Argus have to say about CARA? (Argus Research)
Apr-10-23 07:00AM	Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-07-23 08:41AM	We're Not Very Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate (Simply Wall St.)
Mar-14-23 07:00AM	Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report (GlobeNewswire)
Mar-11-23 07:19AM	Things Look Grim For Cara Therapeutics, Inc. (NASDAQ:CARA) After Today's Downgrade (Simply Wall St.)
Mar-08-23 06:59AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 10:46AM	Metas stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market (MarketWatch) -33.23%
10:02AM	Q4 2022 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
09:43AM	Cara Therapeutics stock sinks on larger-than-expected Q4 earnings miss (Yahoo Finance Video)
08:05AM	Meta shares rise after new wave of layoffs, WeightWatchers stock makes gains after results and acquisition; Grindrs stock falls after profit drop (MarketWatch)
Mar-06-23 07:39PM	These 2 Stocks Are Plunging After Hours Monday (Motley Fool)
05:15PM	Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-27-23 10:00AM	Will Cara Therapeutics (CARA) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-21-23 07:00AM	Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 (GlobeNewswire)
Feb-15-23 05:11AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.)
Feb-08-23 05:00PM	Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine (GlobeNewswire)
Jan-17-23 07:00AM	Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023 (GlobeNewswire)
Jan-03-23 07:00AM	Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-22 05:53AM	Cara Therapeutics (NASDAQ:CARA shareholders incur further losses as stock declines 8.8% this week, taking three-year losses to 35% (Simply Wall St.) +8.61%
Nov-29-22 07:30AM	KemPharm Announces Appointment of Christopher Posner as New Independent Director (GlobeNewswire)
Nov-09-22 06:08AM	Cara Therapeutics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-07-22 05:35PM	Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Cara Therapeutics Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-04-22 08:46AM	Why Cara Therapeutics (CARA) Might Surprise This Earnings Season (Zacks)
Nov-03-22 07:00AM	Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors (GlobeNewswire)
Nov-02-22 10:01AM	Analysts Estimate Affimed N.V. (AFMD) to Report a Decline in Earnings: What to Look Out for (Zacks) -5.80%
07:00AM	Cara Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-31-22 10:00AM	Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-30-22 08:51AM	Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 67% (Simply Wall St.)
Oct-24-22 07:00AM	Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022 (GlobeNewswire)
Oct-18-22 09:55AM	Wall Street Analysts See a 133% Upside in Cara (CARA): Can the Stock Really Move This High? (Zacks)
Oct-10-22 04:05PM	SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics (PR Newswire)
Sep-28-22 07:00AM	Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted in Japan (GlobeNewswire)
Sep-20-22 09:47AM	Here's Why We're Not Too Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Situation (Simply Wall St.)
Sep-12-22 07:00AM	Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer (GlobeNewswire)
Sep-08-22 02:27PM	Cara Therapeutics Presents Results of Oral Difelikefalin In Painful Itching Disorder (Benzinga)
08:15AM	Cara Therapeutics Presents Late-Breaking Results of the KOMFORT Phase 2 Trial of Oral Difelikefalin for Pruritus in Notalgia Paresthetica at the 31st EADV Congress (GlobeNewswire)
Sep-06-22 07:00AM	Cara Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-24-22 07:00AM	Cara Therapeutics to Host Virtual Notalgia Paresthetica Event on September 20, 2022 (GlobeNewswire)
Aug-22-22 07:00AM	Cara Therapeutics Announces KOMFORT Data Accepted for Late-Breaking Presentation at the 31st EADV Congress (GlobeNewswire)
Aug-19-22 01:00AM	Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022 (GlobeNewswire)
Aug-08-22 05:15PM	Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Cara Therapeutics Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-04-22 08:48AM	Should You Buy Cara Therapeutics (CARA) Ahead of Earnings? (Zacks) +12.26%
Aug-03-22 07:00AM	Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire) +7.02%
Aug-01-22 04:01PM	Cara Therapeutics to Announce Second Quarter 2022 Financial Results on August 8, 2022 (GlobeNewswire) -5.72%
Jul-28-22 09:14AM	10 Medical Marijuana Stocks to Buy Now (Insider Monkey)
Jul-22-22 06:39AM	Investors in Cara Therapeutics (NASDAQ:CARA) have unfortunately lost 56% over the last three years (Simply Wall St.)
Jun-30-22 10:19AM	Cara Therapeutics' Difelikefalin Aces Mid-Stage Study In Patients With Itchy Skin Disorder (Benzinga)
07:00AM	Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Patients with Notalgia Paresthetica (GlobeNewswire)
Jun-06-22 11:46AM	10 Best CBD Stocks To Invest In (Insider Monkey)
May-23-22 07:04AM	What Type Of Shareholders Own The Most Number of Cara Therapeutics, Inc. (NASDAQ:CARA) Shares? (Simply Wall St.)
May-17-22 07:00AM	Cara Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire) +6.18%
May-09-22 05:25PM	Cara Therapeutics (CARA) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -7.34%
04:01PM	Cara Therapeutics Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-04-22 09:05AM	Vericel Corporation (VCEL) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-03-22 04:01PM	Cara Therapeutics to Present at May Investor Conferences (GlobeNewswire)
Apr-29-22 07:00AM	Cara Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022 (GlobeNewswire) -8.88%
Apr-28-22 01:00AM	Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients (GlobeNewswire) -5.25%
Apr-13-22 11:17AM	J.P. Morgan: These 3 Stocks Could Spike at Least 40% (TipRanks)
07:46AM	Cara Therapeutics (NASDAQ:CARA) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Apr-05-22 07:00AM	Cara Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-04-22 04:01PM	Cara Therapeutics Announces Biomarker Data from KALM-1 and KALM-2 Trials of KORSUVA (difelikefalin) Injection Selected for Presentation at National Kidney Foundation Spring Clinical Meetings 2022 (GlobeNewswire)
Mar-28-22 12:13PM	Cara Therapeutics' Difelikefalin Improves Itch, Inflammatory Biomarkers In Skin Disorders (Benzinga)
07:00AM	Cara Therapeutics Announces Oral KORSUVA (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus (GlobeNewswire)
Mar-08-22 04:01PM	Cara Therapeutics Announces Oral KORSUVA (difelikefalin) Data Selected for Late-Breaking Presentation at 2022 American Academy of Dermatology Annual Meeting (GlobeNewswire) +11.00%

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Posner Christopher	President and CEO	Nov 02	Sale	1.22	3,796	4,631	164,411	Nov 03 04:37 PM
Posner Christopher	President and CEO	Aug 03	Sale	3.07	4,307	13,222	168,207	Aug 04 05:21 PM
Menzaghi Frederique Ph.D.	Chief Scientific Off,SVP-R&D	Jun 23	Sale	3.51	2,993	10,505	153,747	Jun 27 04:08 PM
Goncalves Joana	Chief Medical Officer	Jun 23	Sale	3.51	2,723	9,558	53,681	Jun 27 04:07 PM
Terrillion Scott	Sec'y; Chief Compliance & G.C.	Jun 23	Sale	3.51	2,483	8,715	88,563	Jun 27 04:09 PM
Posner Christopher	President and CEO	May 05	Sale	4.40	3,869	17,024	172,514	May 09 04:22 PM
Menzaghi Frederique Ph.D.	Chief Scientific Off,SVP-R&D	Apr 04	Sale	4.91	2,733	13,419	156,740	Apr 06 05:12 PM
Terrillion Scott	Sec'y; Chief Compliance & G.C.	Apr 04	Sale	4.91	2,481	12,182	91,046	Apr 06 05:14 PM
Goncalves Joana	Chief Medical Officer	Apr 04	Sale	4.91	2,481	12,182	56,404	Apr 06 05:13 PM
Menzaghi Frederique Ph.D.	Chief Scientific Off,SVP-R&D	Mar 03	Sale	9.71	6,802	66,047	159,473	Mar 07 04:46 PM
Terrillion Scott	Sec'y; Chief Compliance & G.C.	Mar 03	Sale	9.71	6,256	60,746	93,527	Mar 07 04:44 PM
Goncalves Joana	Chief Medical Officer	Mar 03	Sale	9.71	6,221	60,406	58,885	Mar 07 04:43 PM
Posner Christopher	President and CEO	Mar 03	Sale	9.71	5,987	58,134	176,383	Mar 07 04:47 PM
Goncalves Joana	Chief Medical Officer	Feb 16	Sale	10.20	2,265	23,103	65,106	Feb 17 04:27 PM
Posner Christopher	President and CEO	Feb 02	Sale	11.80	4,191	49,454	182,370	Feb 03 06:38 PM
Goncalves Joana	Chief Medical Officer	Jan 17	Sale	10.81	2,265	24,485	67,371	Jan 19 04:18 PM
Goncalves Joana	Chief Medical Officer	Dec 29	Sale	10.18	2,265	23,058	69,636	Jan 03 04:32 PM
Menzaghi Frederique Ph.D.	Chief Scientific Off,SVP-R&D	Dec 21	Sale	11.27	3,506	39,513	166,275	Dec 23 04:54 PM
Goncalves Joana	Chief Medical Officer	Dec 21	Sale	11.27	2,992	33,720	71,901	Dec 23 04:53 PM
Terrillion Scott	Sec'y; Chief Compliance & G.C.	Dec 21	Sale	11.27	2,561	28,862	99,783	Dec 23 04:52 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CARA

Cara Therapeutics Inc

Upgrade your FINVIZ experience